Conference Coverage: ASH 2024 – Focus on Multiple Myeloma

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding multiple myeloma

December 13, 2024
Purchase Report

FACULTY CHAIR

Rafael Fonseca, MD

Mayo Clinic, Phoenix, AZ, USA

Faculty Members

Leif Bergsagel, MD
Mayo Clinic, Phoenix, AZ, USA

Andrzej Jakubowiak, MD, PhD​
University of Chicago, Chicago, IL, USA

Sagar Lonial, MD, FACP
Emory University, Atlanta, GA, USA

Keith Stewart, MB, ChB, MBA
Princess Margaret Cancer Centre, Toronto, ON, Canada

Gareth Morgan, MD, PhD, FRCP, FRCPath
Perlmutter Cancer Center, New York, NY, USA

María-Victoria Mateos, MD, PhD
University of Salamanca, Spain

Sample Report

Start discovering the insights

View Report

REPORT BACKGROUND

  • Clinical experts from across the world will discuss global perspectives on current treatment strategies and emerging therapies in multiple myeloma derived from ASH 2024 data
  • The goal of the expert panel will be to critique and debate new evidence in multiple myeloma and gain strategic insight into the most impactful abstracts from the ASH meeting with respect to shaping current research directions and/or changing the scope of practical clinical care

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.